Steven M. Greenberg, MD, PhD, FAHA, Chair; Wendy C. Ziai, MD, MPH, FAHA, Vice Chair;
Charlotte Cordonnier, MD, PhD; Dar Dowlatshahi, MD, PhD, FAHA; Brandon Francis, MD …

Intracerebral haemorrhage (ICH) is a dramatic condition caused by the rupture of a cerebral
vessel and the entry of blood into the brain parenchyma. ICH is a major contributor to stroke …

Background The use of antithrombotic agents, including anticoagulants, antiplatelet agents,
and thrombolytics has increased over the last decade and is expected to continue to rise …

The aim of the present European Stroke Organisation guideline document is to provide
clinically useful evidence-based recommendation on reversal of anticoagulant activity VKA …

Acute Stroke - StatPearls - NCBI Bookshelf US flag An official website of the United States
government Here's how you know NIH NLM Logo Access keys NCBI Homepage MyNCBI …

BACKGROUND The number of anticoagulated trauma patients is increasing. Trauma
patients on warfarin have been found to have poor outcomes, particularly after intracranial …

Objective There is little evidence to guide treatment strategies for intracerebral hemorrhage
on vitamin K antagonists (VKA‐ICH). Treatments utilized in clinical practice include fresh …

Warfarin is effective for the prevention and treatment of thromboembolism but produces
variable anticoagulant effects and requires routine monitoring of the international …

Prothrombin complex concentrates (PCC) can rapidly normalise prolonged prothrombin
time, induced by vitamin K antagonists (VKA). We conducted a multicentre retrospective …

Spontaneous intracerebral hemorrhage is a type of stroke associated with poor outcomes.
Mortality is elevated, especially in the acute phase. From a pathophysiological point of view …